Resources
124 Results (showing 1 - 10)
Results sorted by posted date (oldest first)
Results sorted by posted date (oldest first)
Posted 11/21/2019 (updated 3/28/2024)
This report was developed as part of an initiative of the U.S. Department of Health and Human Services (HHS) Office on Women’s Health (OWH) to examine prevention, treatment, and recovery issues for women who misuse opioids, have opioid use disorders (OUDs), and/or overdose on opioids.
Posted 12/3/2019 (updated 3/28/2024)
Billing Behavioral Health Medicaid Services Under Managed Care in New York State.
Posted 1/22/2020 (updated 3/28/2024)
How Science Has Revolutionized the Understanding of Drug Addiction. PDF version of this resource is available in English and Spanish.
Posted 3/19/2020 (updated 3/28/2024)
To help local leaders respond to this epidemic, USDA has worked to build infrastructure for prevention, treatment and recovery, facilitate partnerships, and drive innovation in rural communities.
Posted 4/3/2020 (updated 3/28/2024)
This RSV Breakout Session for RCORP Implementation and MAT Expansion grantees was held in the Independence Ballroom Salons D & E on Friday, March 6, 2020, at 11:15 AM
Posted 4/3/2020 (updated 3/28/2024)
This RSV Rapid Fire Session was held in the Independence Ballroom Salons D & E on Friday, March 6, 2020, at 9:00 AM
Posted 4/3/2020 (updated 3/28/2024)
This RSV Breakout Session was held in the Archives Room on Wednesday, March 5, 2020, at 2:30 PM
Posted 4/27/2020 (updated 3/28/2024)
The Advanced Primary Care-Alternative Payment Model (APC-APM) embodies the principle that patient-centered primary care is comprehensive, continuous, coordinated, connected, and accessible from the patient’s first contact with the health system.
Posted 5/11/2020 (updated 3/28/2024)
This fact sheet describes changes to Oregon Health Authority (OHA) reimbursement for Medication-Assisted Treatment drugs administered to fee-for-service Oregon Health Plan members, effective January 1, 2019.
Posted 5/11/2020 (updated 3/28/2024)
Medication assisted treatment (MAT) will be offered to patients who have a current diagnosis of opioid use disorder (OUD), moderate to severe, and who meet predetermined criteria.